The GH fragment that works on fat
The ReferenceBenefits, protocols and preparationOpen the reference →The part of GH that moves fat, without the rest.
Triggers fat release from the fat cell in animal models.
Does not activate the growth axis: no rise in IGF-1.
Without the insulin resistance full GH causes.
Cartilage repair signal in animals · exploratory.
Peptides often synergize. These are the most studied combinations with this product, and what outcome they target.
Any combination must respect each peptide's protocol. If you have doubts about dosing or timing, message us before starting.
AOD-9604 is the tail end of growth hormone (amino acids 176-191, with an extra tyrosine), the part that in animal studies mobilizes fat. It does not raise IGF-1 or disturb glucose the way full GH does.
SuperBio Labs AOD-9604 is supplied as lyophilized powder with HPLC purity ≥99%, with a Certificate of Analysis per lot.
It has more human history than almost any peptide of its kind: several trials and a phase 2b that did not beat placebo on weight. So we do not sell it as a fat burner: we use it as support inside a metabolic stack.
Informed professional research use only.
We don't just hand you the vial. Every AOD-9604 purchase includes everything you need to apply it safely, with a clear protocol and our team available 24/7.
Lyophilized · HPLC purity ≥99% · Batch with COA
Sterile diluent · 0.9% benzyl alcohol
21G needle · For peptide reconstitution
30 units · daily · 30-day cap
1 per application + 1 to reconstitute
Free app · Week-by-week protocol, product sheet and usage guide
8 steps · From opening the kit to application
App · Tracking · Human team 24/7
About supplies: the quantity of syringes and wipes adjusts automatically based on the presentation you choose. For extended cycles (AOD-9604, GHK-Cu and similar) we cap supplies at 30 days — beyond that, 29G insulin syringes and 70% alcohol wipes are pharmacy items available without prescription in any city.
This product meets all five — your batch COA ships with the kit.
The official protocol included in the kit. If you have pre-existing medical conditions, consult a professional before starting.
No ramp-up: 1 mg from week 1 through 6.
Combine with TB-500 for accelerated recovery. Local application recommended.
Adds lipolysis to satiety · does not replace the GLP-1.
Localized fat at the end of a process · modest expectations.
Fat metabolism through two different pathways.
For those who want to avoid raising IGF-1.
Cartilage signal in animals · secondary use.
Well tolerated in human trials. Adverse events were similar to placebo.
Most reported: redness at the application site · mild headache. Not used with active cancer. Pregnancy and breastfeeding: no data. For athletes: on the WADA list (S2).
| Also known as | hGH fragment 176-191 (Tyr) |
| CAS number | 221231-10-3 |
| Molecular weight | ≈1815 Da |
| Sequence | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe |
| Purity (HPLC) | ≥99% |
| Format | Lyophilized powder |
| Quantity | 10 mg per vial |
| Endotoxins | <1.0 EU/mg |
| Storage | −20 °C, protected from light |
| Use | Use under professional judgment |